Higher-Volume Hospitals Have Better Laryngectomy Outcomes
Reduced morbidity associated with a minimum hospital volume threshold of six cases/year
FDA Approves Firdapse for Rare Autoimmune Disorder
First agency-sanctioned treatment for adults with Lambert-Eaton myasthenic syndrome
RSNA: Mammography May Benefit 30-Year-Olds With Risk Factors
Early screening may benefit those with dense breasts, personal/family history of breast cancer
FDA Approves First Biosimilar to Non-Hodgkin’s Lymphoma Drug
Truxima approved to treat adults with CD20-positive, B-cell non-Hodgkin's lymphoma
Recommended Therapies for Polycythemia Vera Underused
Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients
One in Five Readmitted After Head, Neck Cancer Reconstruction
Both sociodemographic and clinical features up the rate of readmission
Four Principles Underlie Patient and Family Partnership in Care
Patients, families should be treated with dignity and respect, be actively engaged in care
FDA to Update Medical Device Approvals Process
Revised process will ensure new medical devices meet safety and effectiveness standards
FDA Approves Vitrakvi for Cancers With Certain Genetic Trait
Drug targets solid tumors with NTRK gene fusion without a known acquired resistance mutation
ADT May Up Risk for Heart Failure in Prostate Cancer Patients
Heart failure risk higher for androgen deprivation therapy users in propensity score-matched analysis
